Dissolving and hydrogel-based polymeric microneedles for bacterial keratitis: materials, therapeutic payloads, design-performance relationships, and future perspectives.
Peirovi Babak B, Amanzadi Bentolhoda B, Censi Roberta R, Aghamollaei Hossein H
Bacterial keratitis (BK) is a major cause of corneal visual impairment. Although topical antibiotics remain the mainstay of treatment, tear turnover, blinking, nasolacrimal drainage, and the corneal epithelial barrier limit drug residence and penetration. Polymeric microneedles, particularly dissolving and hydrogel-based systems, may enhance ocular residence of therapeutic agents and enable controlled or sustained drug release. This review summarizes corneal anatomy and ocular drug-delivery barriers, outlines the pathophysiology of bacterial keratitis, and evaluates microneedle platforms developed for ocular applications, with emphasis on dissolving and hydrogel-based polymeric systems for bacterial keratitis. A focused search of PubMed, Scopus, and ScienceDirect was undertaken, supplemented by a search of Google Scholar to identify additional relevant studies. Relevant studies were compared according to polymer composition, microneedle dimensions and density, penetration depth, dissolution or swelling, and release kinetics. Polymer design-property relationships, including the effects of concentration, molecular weight, crosslinking, biodegradability, and post-administration polymer fate, are also discussed. Polymeric microneedles offer a promising strategy for overcoming corneal delivery barriers, but clinical translation will depend on reproducible manufacturing, mechanical and ocular safety, sterilization and storage stability, user-friendly application, and robust clinical evidence demonstrating advantages over optimized topical therapies.